Charles River Laboratories International (NYSE:CRL) and Agilon Health (NYSE:AGL) Head-To-Head Comparison

Charles River Laboratories International (NYSE:CRLGet Free Report) and Agilon Health (NYSE:AGLGet Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, risk, analyst recommendations, valuation and institutional ownership.

Profitability

This table compares Charles River Laboratories International and Agilon Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Charles River Laboratories International -4.59% 15.36% 6.61%
Agilon Health -6.09% -146.03% -24.55%

Analyst Recommendations

This is a breakdown of current ratings and price targets for Charles River Laboratories International and Agilon Health, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charles River Laboratories International 1 4 10 0 2.60
Agilon Health 2 8 5 0 2.20

Charles River Laboratories International currently has a consensus price target of $207.69, suggesting a potential upside of 26.21%. Agilon Health has a consensus price target of $58.73, suggesting a potential downside of 35.21%. Given Charles River Laboratories International’s stronger consensus rating and higher probable upside, equities analysts plainly believe Charles River Laboratories International is more favorable than Agilon Health.

Earnings & Valuation

This table compares Charles River Laboratories International and Agilon Health”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Charles River Laboratories International $4.02 billion 1.97 -$144.34 million ($3.76) -43.77
Agilon Health $5.93 billion 0.25 -$391.35 million ($21.56) -4.20

Charles River Laboratories International has higher earnings, but lower revenue than Agilon Health. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Charles River Laboratories International has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500. Comparatively, Agilon Health has a beta of 2.29, indicating that its share price is 129% more volatile than the S&P 500.

Institutional & Insider Ownership

98.9% of Charles River Laboratories International shares are held by institutional investors. 1.3% of Charles River Laboratories International shares are held by company insiders. Comparatively, 2.3% of Agilon Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Charles River Laboratories International beats Agilon Health on 10 of the 14 factors compared between the two stocks.

About Charles River Laboratories International

(Get Free Report)

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

About Agilon Health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Receive News & Ratings for Charles River Laboratories International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charles River Laboratories International and related companies with MarketBeat.com's FREE daily email newsletter.